Issue 46, 2021

Covalent organic framework-engineered polydopamine nanoplatform for multimodal imaging-guided tumor photothermal-chemotherapy

Abstract

A covalent organic framework (COF)-engineered polydopamine core–shell nanoplatform (PDA@COF) was developed. The ultrasmall pores and abundant functional sites of the COF endowed the nanoplatform with enhanced drug loading capacity and diminished drug leakage effect. Multimodal imaging-guided photothermal chemo-synergistic tumor-targeted therapy was realized after rational functionalization. This work offers new insights for developing COF-based multifunctional theranostic systems.

Graphical abstract: Covalent organic framework-engineered polydopamine nanoplatform for multimodal imaging-guided tumor photothermal-chemotherapy

Supplementary files

Article information

Article type
Communication
Submitted
18 Jan 2021
Accepted
04 May 2021
First published
05 May 2021

Chem. Commun., 2021,57, 5646-5649

Covalent organic framework-engineered polydopamine nanoplatform for multimodal imaging-guided tumor photothermal-chemotherapy

P. Gao, R. Wei, X. Liu, Y. Chen, T. Wu, M. Shi, M. Wang, N. Li and B. Tang, Chem. Commun., 2021, 57, 5646 DOI: 10.1039/D1CC00314C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements